STOCK TITAN

Xtant Medical (XTNT) CFO tied to 869,878 unvested shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Xtant Medical Holdings, Inc. reported that its CFO and Assistant Secretary, Scott C. Neils, received a grant of 400,000 deferred stock units (DSUs) of common stock. These DSUs vest in four equal installments of 100,000 shares on each of August 15, 2027, 2028, 2029, and 2030, conditioned on his continued employment, with settlement to occur at a later date. On the same date, 28,155 shares of common stock were withheld at $0.31 per share to cover tax withholding obligations upon vesting and settlement of prior restricted stock unit awards. In total, Neils now has 869,878 shares issuable upon vesting and settlement of RSU and DSU awards, all subject to continued employment through their respective vesting dates.

Positive

  • None.

Negative

  • None.
Insider Neils Scott C
Role CFO and Assistant Secretary
Type Security Shares Price Value
Grant/Award Common Stock F1, F2 400,000 $0.00 $0.00
Tax Withholding Common Stock F3, F2 28,155 $0.31 $9K
Holdings After Transaction: Common Stock — 1,215,226 shares (Direct)
Footnotes (3)
  1. F1. These shares will vest with respect to 100,000 shares on each of August 15, 2027, August 15, 2028, August 15, 2029, and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.
  2. F2. Includes an aggregate of 869,878 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.
  3. F3. These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.
DSU grant 400,000 shares of Common Stock Deferred stock unit award granted to CFO Scott C. Neils on 2026-08-15
DSU vesting schedule 100,000 shares per year DSUs vest on August 15 of 2027, 2028, 2029, and 2030, subject to employment
Tax withholding shares 28,155 shares Shares withheld to pay tax withholding obligations upon RSU vesting and settlement
Tax withholding price $0.31 per share Price used for withholding 28,155 shares for tax obligations
Aggregate unvested awards 869,878 shares Shares issuable upon vesting and settlement of RSU and DSU awards, subject to employment
deferred stock unit (DSU) financial
"These shares will vest ... pursuant to a deferred stock unit (DSU) award granted"
restricted stock unit financial
"Includes an aggregate of 869,878 shares issuable upon vesting and settlement of restricted stock unit awards"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax withholding obligations financial
"These shares were withheld by the Issuer to pay tax withholding obligations upon vesting"
Equity Incentive Plan financial
"granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

What equity award did XTNT grant to CFO Scott C. Neils in this Form 4?

XTNT granted Scott C. Neils 400,000 deferred stock units (DSUs) of common stock, vesting in four equal tranches of 100,000 shares each on August 15 of 2027, 2028, 2029, and 2030, subject to continued employment.

How do the 400,000 DSUs for XTNT’s CFO vest over time?

The 400,000 DSUs vest in four equal installments of 100,000 shares on August 15, 2027, 2028, 2029, and 2030, provided Scott C. Neils remains an employee through each applicable vesting date.

How many XTNT shares are currently issuable to the CFO from equity awards?

An aggregate of 869,878 shares of XTNT common stock are issuable to Scott C. Neils upon vesting and settlement of restricted stock unit and DSU awards, all conditioned on his continued employment through the respective vesting dates.

Does the XTNT CFO’s DSU award settle immediately upon vesting?

No. The filing states that settlement of the vested shares underlying the DSU award is deferred and will occur at a later date under the DSU award agreement, even though each DSU represents one share of common stock.

Under which plan were the XTNT equity awards to the CFO granted?

Both the DSU award and the referenced restricted stock unit awards were granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, which governs their vesting and settlement terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Neils Scott C

(Last)(First)(Middle)
C/O XTANT MEDICAL HOLDINGS, INC.
664 CRUISER LANE

(Street)
BELGRADE MONTANA 59714

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Xtant Medical Holdings, Inc. [ XTNT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CFO and Assistant Secretary
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/15/2026A400,000(1)A$01,243,381(2)D
Common Stock08/15/2026F(3)28,155(3)D$0.311,215,226(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares will vest with respect to 100,000 shares on each of August 15, 2027, August 15, 2028, August 15, 2029, and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.
2. Includes an aggregate of 869,878 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.
3. These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.
/s/ Amy Culbert, attorney-in-fact08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)